In a survey of 377 buprenorphine prescribers in Michigan, high-threshold practices such as requiring counseling as a condition for buprenorphine treatment and conducting drug testing during every in-office visit were associated with higher rates of treatment termination for patients receiving buprenorphine. Buprenorphine treatment continuity is critical to preventing overdose deaths amidst an intensifying national overdose crisis. State policy reforms encouraging practices to retain patients in treatment even if they do not strictly adhere to counseling recommendations and limiting drug testing to a clinically relevant frequency could improve overall patient engagement with buprenorphine treatment and save lives.
Published January 16, 2024
Sign up to receive our monthly Research Roundup email, which offers a selection of new public health research from major journals.
Recent Abstracts
Strengthening the Civil Registration and Vital Statistics (CRVS) System in Colombia
Estimation of the direct and indirect costs attributable to alcohol consumption in Brazil
Guidance for Collection and Processing of Cause-of-Death Data in the Civil Registration and…
Vital Strategies: Reimagine Public Health
Public perceptions of emissions testing in Jakarta, Indonesia
Cost-Benefit Analysis for Air Pollution Control Strategies in Jakarta
Key Messages on Alcohol Harms and Policy Solutions
Flooding and Early Childhood Development
RESET Alcohol – Public Attitudes Towards Alcohol Policy in Mexico
Estimating the annual production data of bidi sticks in India using the “back-of-the-envelop”…